Menu

Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug

By Addeo Raffaele in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro

By Jeong Seongwook,Woo Margaret,Flockhart David,Desta Zeruesenay in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer

By Zang Dae,Yang Dae,Kim Min-Jeong,Jang Kyung,Hwang Se,Yoo Kyo-Sang,Han Taeho,Kim Ho,Kim Hyo,Kwon Jung,Song Hun,Park Sarah,Jung Joo,Kim Hyeong,Kim Jung in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer

By Miyake Kotaro,Shimada Mitsuo,Nishioka Masanori,Sugimoto Koji,Batmunkh Erdenebulgan,Uto Yoshihiro,Nagasawa Hideko,Hori Hitoshi in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group

By Comella Pasquale,Lorusso Vito,Maiorino Luigi,Casaretti Rossana,Cannone Michele,Massidda Bruno,Putzu Carlo,Leo Silvana,Roselli Mario,Mancarella Sergio,Palmeri Sergio,Greco Ettore,Vessia Giacomo,Sandomenico Claudia,Franco Luca in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

By Atzpodien Jens,Morawek Lars,Fluck Michael,Reitz Martina in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

By Corazzelli Gaetano,Capobianco Gaetana,Arcamone Manuela,Ballerini Pier,Iannitto Emilio,Russo Filippo,Frigeri Ferdinando,Becchimanzi Cristina,Marcacci Gianpaolo,Chiara Annarosaria,Pinto Antonio in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer

By Chang Myung,Kim Kyoung,Jun Hyun,Kim Hyo,Yi Seong,Uhm Ji,Park Min,Lim Do,Ji Sang,Hwang In,Lee Jeeyun,Park Yeon,Ahn Jin,Ahn Myung-ju,Park Keunchil in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines

By Perry Jackie,Powles Thomas,Shamash Jonathan,Veerupillai Arthi,McGrowder Eva,Noel Elodie,Lu Yong-Jie,Oliver Tim,Joel Simon in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies

By Tse Archie,Wu Nian,Patel Dina,Haviland Dana,Kemeny Nancy in (2009)

Springer Publishing Company

Abstract Access to resources Recommend Favorite